Click Therapeutics

Call
Website
855 Boylston St Ste 10
Boston, MA 02116
+1 (857) 263-8410
https://clicktherapeutics.com

Click Therapeutics, based in Boston, MA, is pioneering the field of digital medicine by creating patient-centric digital treatments that integrate neuroscience with software technology. Their innovative platform develops, validates, and commercializes software as prescription medical treatments aimed at addressing unmet medical needs across various health conditions.

The company's Software-Enhanced Drugs (Click SE) combine pharmacotherapy with digital therapeutics to provide enhanced clinical benefits to patients. By employing a multimodal approach, Click Therapeutics targets diseases from multiple angles, leveraging scientifically proven therapies alongside proprietary neuromodulatory mechanisms for clinically significant interventions.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Synlogic

Synlogic

A clinical-stage drug discovery and development company applying synthetic biology to beneficial microbes to develop novel living medicines.
United States›Massachusetts›Boston›Click Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.